Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q96HP4
UPID:
OXND1_HUMAN
Alternative names:
-
Alternative UPACC:
Q96HP4; Q2HYC7; Q59FA4
Background:
Oxidoreductase NAD-binding domain-containing protein 1 plays a crucial role in cellular redox processes. This protein, encoded by the gene with the accession number Q96HP4, is pivotal in the regulation of oxidation-reduction reactions, facilitating the transfer of electrons between molecules. Its involvement in these fundamental biochemical pathways underscores its importance in maintaining cellular homeostasis and energy production.
Therapeutic significance:
Understanding the role of Oxidoreductase NAD-binding domain-containing protein 1 could open doors to potential therapeutic strategies. Its central role in redox biology suggests that modulation of its activity could have therapeutic implications in diseases characterized by oxidative stress or metabolic imbalances.